ReviewEpileptic disorders : international epilepsy journal with videotape2026
Laser interstitial thermal therapy for refractory epilepsy in children under 2 years: A single-center case series and review of the literature.
Review in Epileptic disorders : international epilepsy journal with videotape, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the safety, feasibility, and clinical outcomes of magnetic resonance-guided laser interstitial thermal therapy (LITT) in children under 2 years of age with medically refractory epilepsy.
methodsWe conducted a retrospective case series of five infants who underwent LITT at a tertiary pediatric epilepsy center. Inclusion criteria were age ≤ 24 months, failure of at least two antiseizure medications, and presence of a focal structural lesion on imaging. Clinical data, seizure outcomes (Engel classification), and developmental trajectories were analyzed.
resultsFive patients (mean age at LITT: 9 months) underwent laser ablation for focal cortical dysplasia (FCD; n = 3) or tuberous sclerosis complex (TSC; n = 2). All patients tolerated the procedure without complications. At 12 months post-LITT, 3/5 patients (60%) achieved Engel Class I outcomes, all of whom had FCD. Both patients with TSC had ongoing seizures, although one showed improvement after subsequent SEEG-guided open resection. Patients with FCD demonstrated robust developmental progress, whereas those with TSC exhibited only modest gains in attention, engagement, and fine motor skills.
conclusionLITT is a safe and feasible option for selected infants with drug-resistant epilepsy and structural lesions. Favorable seizure and developmental outcomes were more commonly observed in patients with FCD than TSC. These findings support further study of LITT in this age group, with particular attention to early intervention and accurate localization in complex cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.